Explore our Year-in-Review webpage for 2024’s key moments, achievements, and insights shaping the future.

Our Year-in-Review webpage was designed to highlight the key moments and achievements of 2024. It serves as a reflection on the progress and milestones reached across our organization. On this page, you’ll find a compelling video summarizing the year’s highlights, along with news and insights from our scientific departments.

In 2021, a research team led by Prof. Heiko Lickert from Helmholtz Munich discovered the insulin-inhibitory receptor "Inceptor" and its role as a suppressor of the insulin signaling pathway. Now, the researchers have unlocked another, even more…

gespräch-ärztin-01-institut-fotoshooting-nozy-andreas pfohl-220727_0134

Almost nine million people are living with type 1 diabetes worldwide. Although this disease can be a life-threatening, it often goes unnoticed and is diagnosed too late. Yet type 1 diabetes can be diagnosed early, long before symptoms appear, by a…

Veranstaltung im Bergson_Abnehmspritze_Matthias Tschöp_Matthias Blüher

On October 22, science and culture converged in an exciting collaboration between Helmholtz Munich and the Bergson Kunstkraftwerk. At the inaugural event of the three-part Bergson Academy series, experts from Helmholtz Munich, along with a patient,…

The Type 1 Diabetes Grand Challenge, a partnership between the Steve Morgan Foundation, Diabetes UK, and Breakthrough T1D, formerly JDRF, has announced funding for a cutting-edge research project led by researchers at Helmholtz Munich and the…

Dr Maria Keller, project leader at the Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of Helmholtz Munich in Leipzig, has been awarded this year's research prize of the German Obesity Society (DAG) for her work in the field…

Every year on October 3rd, the German broadcaster WDR organizes the event "Doors Open with The Mouse." This year, 770 companies and research institutions across Germany participated, welcoming children and parents under the theme "Working Together."…

The German Research Foundation (DFG) has awarded nearly five million euros to fund a four-year research project on metabolic health, led by the Technical University of Munich (TUM) with significant involvement from Helmholtz Munich. Researchers from…

Rachmiel Levine Award for Anette-Gabriele Ziegler

Prof. Anette-Gabriele Ziegler, Director of the Helmholtz Munich Institute for Diabetes Research, was awarded the 2024 Rachmiel Levine Medal by City of Hope - a prominent biomedical research and treatment institution in the United States, especially…

The 11th Helmholtz Diabetes Conference, held from September 23 to 25, 2024, in Munich, gathered leading international experts to discuss advancements in diabetes and metabolic research. Hosted by Stephan Herzig, Maria Rohm, and Mauricio Berriel Diaz…

Researchers at Helmholtz Munich have received an award from Breakthrough T1D, a leading global type 1 diabetes (T1D) research and advocacy organization, to fund a new diabetes research project. The project will leverage advanced artificial…

Experts from the Helmholtz Munich-led Fr1daPlex initiative, the Bavarian Professional Association of Pediatricians (BVKJ), and PaedNetz Bayern e.V. have published a new position paper providing a detailed evaluation of an islet autoantibody screening…

Dr. Bilal Sheikh, group leader of the Young Investigator’s group “Vascular Epigenetics” at the Helmholtz Institute for Metabolic, Obesity and Vascular Research, has been selected as a Henriette-Herz Scout by the Alexander von Humboldt Foundation.…

Kinder in einem Labor machen Experimente

This summer and fall, Helmholtz Munich will participate in three major community events in Munich: the FORSCHA, the OBEN OHNE Festival, and the Maus Türöffner-Tag. These engagements highlight Helmholtz Munich’s commitment to fostering public interest…

On June 12, 2024, the National Strategy for Gene and Cell Therapies was unveiled at the Futurium in Berlin.

At the Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) in Leipzig, two metabolic chambers for humans have been constructed with the objective of determining the influence of obesity and other metabolic diseases on energy…

Artwork features an allegorical representation of a fertilization event

A recent study conducted by Helmholtz Munich and the German Center for Diabetes Research provides new insights into how fathers' diets and overweight can affect their children's health even before conception. The findings of the study can help…

At the third Helmholtz Munich Expert Hour at the German Bundestag on June 4, 2024, the cutting-edge research center provided information on the potential of artificial intelligence (AI) and new technologies to improve medicine in the areas of…

This year, the highest award of the German Diabetes Association (DDG) – the Paul Langerhans Medal – is awarded to Prof. Dr. med. Anette-Gabriele Ziegler. The Director of the Institute of Diabetes Research at Helmholtz Munich and scientist at the…

Happy millennial african american mother kissing little child, enjoy relax together, have fun in bedroom interior

Type 1 diabetes is an autoimmune disease that leads to disrupted glucose metabolism. It requires lifelong insulin therapy. The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) collaborates within a European network to develop new…

Prof. Anette-Gabriele Ziegler about her contribution to novel therapies for type 1 diabetes.

During the 2nd Helmholtz Munich Expert Hour on April 10, 2024, representatives from politics and science gathered once again to discuss pressing health issues and stay informed about the latest developments in research. The topic "When will diabetes…

Prof. Stephan Herzig explains why intermittent fasting with conscious breaks of eating helps to bring the metabolism into harmony with the body's internal rhythm and thus improve health and prevent diseases such as diabetes, cardiovascular diseases,…

Recent research underscores the critical role of adipocytes in storing fat, vital for organismal survival. Dysfunctional adipocytes can lead to metabolic disorders like type 2 diabetes and fatty liver disease, highlighting the importance of…

Prof. Antje Körner, Head of the Metabolism Division at the Helmholtz Institute of Metabolic, Obesity and Vascular Research (HI-MAG) at Helmholtz Munich and Professor of Metabolic Research at Leipzig University’s Faculty of Medicine, has been named as…

INFRAFRONTIER, a leading player in biomedical research infrastructure, headquartered at Helmholtz Munich, was officially declared as a European Research Infrastructure Consortium (ERIC) by the European Commission. This milestone represents a…

Research targeting the insulin-inhibitory receptor, called inceptor, unveils promising avenues for beta cell protection, offering hope for causal diabetes therapy. A novel study in mice with diet-induced obesity demonstrates that the knock-out of…

Sex-Specific Research

Helminth Worm In Macrophage Generated By AI

A research team led by Prof. Julia Esser-von Bieren from the Center of Allergy and Environment (ZAUM) at Helmholtz Munich and the Technical University of Munich, as well as the University of Lausanne (UNIL) has uncovered a molecular strategy employed…

Dr. med. habil. Katharina Lechner, Medical Lead of the KORA Digital-Fit Intervention Study, Helmholtz Munich

Katharina Lechner's goal is to help people age healthily. That's why she focuses on personalized prevention strategies. Find here how she plans to implement these and make them accessible to everyone.

Munich-Chicago-Lung-Conference-2024-Gruppenbild

Leading lung health experts from the U.S. and Europe gathered in Hohenkammer, near Munich, for the second edition of the Munich-Chicago Lung Conference. Building on last year’s success in Chicago, this year’s event continued to push the boundaries of…

WBGU_Uebergabe_2024_Claudia Traidl-Hoffmann

Prof. Claudia Traidl-Hoffmann has been reappointed for a second consecutive term to the German Advisory Council on Global Change (WBGU). This reappointment underscores the crucial role of environmental medicine in scientific policy advising. Over the…

Woman with bottle of water suffering from heat stroke outdoors

The 2024 global Lancet Countdown report on climate change and health underscores that the adverse effects of the climate crisis have reached unprecedented levels worldwide – especially concerning human health. Researchers from Helmholtz Munich…

In its new report “Water in a Heated World”, the German Advisory Council on Global Change (WBGU) warns of an increasing worsening of global water emergencies. The experts, including Helmholtz Munich researcher Prof. Claudia Traidl-Hoffmann, presented…

An international study led by Helmholtz Munich investigates the health consequences of heavy rainfall events. Researchers analyzed the relationship between precipitation patterns and mortality rates at 645 locations across 34 countries from 1980 to…

The largest repository of human biosamples in Germany is located at the Helmholtz Munich campus. It features cutting-edge robotics and stores a valuable scientific collection at extremely low temperatures of up to -180°C. Researchers use these…

Dr. Varun Kumar from Helmholtz Munich has been awarded a grant from the German Research Foundation (DFG) to study how cells repair damaged DNA, with a focus on a protein called nuclear RAGE (nRAGE). This funding will support research aimed at…

A highmagnification image of a cell with brightlylabeled ubiquitin molecules busy marking target proteins for degradation Von Justlight

A new project funded by the German Research Foundation (DFG) with an 18-million-euro grant is exploring the potential of the ubiquitin system for cancer therapies. Led by the Technical University of Munich (TUM), this four-year research initiative…

Five prestigious Starting Grants from the European Research Council have been granted to researchers with Helmholtz Munich as the host institution. The funding will enable scientists at Helmholtz Munich to advance innovative projects across various…

Large city with visible air pollution and smog or fog

Even when air pollutant concentrations decrease, the health risks posed by these pollutants can remain consistently high. This is the conclusion of an international study recently conducted under the leadership of researchers from Helmholtz Munich. A…

Dr. Lena Cords, a researcher at Helmholtz Munich, has been awarded the German Study Prize by the Körber Foundation in the category of natural and technical sciences for her doctoral thesis at the University of Zurich and ETH Zurich. The prize is…

How researchers from Helmholtz Munich are making wheat, oats, barley, and co. fit for the future.

Knowledge bites about the impact of high-salt diet on allergic asthma and the driving force of these new insights on personalized medicin. Learn about the latest findings in an interview with Prof. Francesca Alessandrini.

The research results…

Environmental scientists in Augsburg from IEM / Helmholtz Munich and the University Hospital Augsburg are now using a cutting-edge measuring device capable of detecting complex aerosols, among them for example very small pollen, or other particles.…

Helmholtz Munich is researching how heat and cold affect people with chronic diseases as part of the Augsburg KORA Study.

["Structure Reference Image","Structure Reference Image","Reference Image","Generated image"]

Driven by climate change, heatwaves are becoming increasingly frequent and prolonged in Germany. Especially for older adults, children, and people with pre-existing conditions, extreme heat can pose a health risk.

Interview with Prof. Annette Peters about how to protect yourself better against heat.

Interview with Prof. Claudia Traidl-Hoffmann about healthcare and resilience to heat and other effects of climate change.

In a recent study, researchers from Helmholtz Munich and the Augsburg University Hospital show that nocturnal heat significantly increases the risk of stroke. The findings can contribute to the development of preventive measures: With them, the…

A new research initiative, spearheaded by Prof. Michael Schloter in collaboration with Dr. Laura Wengenroth from the LMU Hospital Munich, is dedicated to exploring how the rural environment provides long-term protection against asthma and allergies.…

A mystery that has puzzled the scientific community for over 50 years has finally been solved. A team from Helmholtz Munich and Linköping University, Sweden, has discovered that a certain type of chemical reaction can explain why organic matter found…

Interview with Prof. Önder Yildirim about nutrition and COPD.

Scientists have reached a milestone in the research of childhood asthma. For the first time, they have clarified how a certain genetic defect in children initially leads to frequent infections and later to asthma. The study, published in the American…

An interview with Prof. Markus Diefenbacher, new Principal Investigator (PI) at the Helmholtz Munich Institute for Lung Health and Immunity

Prof. Claudia Traidl-Hoffmann explains how climate change affects our health. The environmental medicine specialist focuses on the prevention of allergic diseases such as hay fever and neurodermatitis.

EU Project PerForM-REACT Strengthens Pandemic Preparedness Efforts

On March 11, 2024, the inauguration of the expanded safety laboratory in Augsburg marked a milestone within the EU-funded "PerForM-REACT" project, aimed at enhancing pandemic…

How do ageing and environmental stress promote chronic inflammatory diseases? Maja Funk, new PI at the Institute of Lung Health and Immunity (LHI) at Helmholtz Munich is getting to the bottom of this question. Together with her team, she investigates…

Many cancer patients develop severe dermatitis during radiotherapy. Which factors increase the risk of such radiodermatitis has only been partially understood up until now. A pilot study at the University of Augsburg, Helmholtz Munich, and the…

A collaborative research project between scientists from Helmholtz Munich, Goethe University Frankfurt, Ludwig Maximilian University Munich, and Technion, the Israel Institute of Technology in Haifa, on “Understanding and Targeting…

On November 25, 2024, Helmholtz Munich hosted an inspiring evening at the Bergson Kunstkraftwerk in Munich. The event, titled "Fit for the Future – How can AI revolutionize Health and Medicine?", brought together experts including Dr. Carsten Marr…

Carsten Marr, Director Institute of AI for Health

The jury for the Eugen Münch Award for Innovative Healthcare has announced the winners for 2024. In the category "Science and Practical Application," Dr. Carsten Marr from Helmholtz Munich was honored for his groundbreaking research on AI-driven…

Microscopic image of a brain organoid, cross section.

In a novel international study, researchers have created the Human Neural Organoid Cell Atlas (HNOCA). This atlas integrates 1.7 million single-cell transcriptomic profiles, offering a powerful tool for studying brain development, disease mechanisms,…

Digital DNA Strand Map Displaying Real time Genetic Data Retrieval and Storage Concept

Helmholtz Munich launches the Helmholtz Munich Imputation Server, providing an imputation service for researchers based in the European Union (EU) and beyond. Imputation is the statistical inference of unobserved genotypes and plays a pivotal role in…

Prof. Zeynep Akata is selected as one of the leading "Top 40 Under 40". Read her compelling interview!

Prof. Stefan Bauer advocates for the democratization and transparency of machine learning research. Read more in this Interview with the AI-expert and Senior PI.

The German Federal Ministry of Education and Research (BMBF) is funding the new collaborative project CausalNet with nearly two million euros. The goal: to develop a new generation of machine learning over the next three years that can understand…

The Helmholtz Association has announced the winners of its second Helmholtz Foundation Model Initiative call, with Helmholtz Munich playing a key role in two of the three selected projects. These innovative projects – VirtualCell and PROFOUND – are…

Interview with Prof. Matthias Tschöp about health research and prevention with cutting-edge tools.

A team of computational biologists from Helmholtz Munich has been honored with the "Frontiers of Science" award at the International Congress of Basic Science (ICBS) in Beijing. Researchers Fabian Theis, Alexander Wolf, and Philipp Angerer received…

Led by Helmholtz Munich, scientists have developed an accessible software solution specifically designed for the analysis of complex medical health data. The open-source software called “ehrapy” enables researchers to structure and systematically…

Futuristic medical concept with red human lungs

SPACETIME, a consortium project involving Helmholtz Munich and coordinated by VU University Medical Center Amsterdam (VUMC), has received a 12 million euro grant from the EU Mission on Cancer call. Over the next five years, 15 partners across seven…

In this interview, Dr. Vincent Fortuin explains their new approach for reliable AI.

Prof. Dr. Dr. Fabian Theis, Head of the Computational Health Center at Helmholtz Munich and Chair of the Mathematical Modeling of Biological Systems at the Technical University of Munich, has been awarded a two-year grant of $400,000 for the project…

The German Society of Human Genetics (GfH) has awarded Dr. Holger Prokisch of Helmholtz Munich the GfH Medal of Honor for his exceptional contributions to human genetic research. This prestigious award is given annually to researchers who have…

Bavarian AI Council 2024 at Helmholtz Munich

The "Bavarian AI Council," established by the Bavarian State Government, met on June 7, 2024, at Helmholtz Munich. The host was Prof. Fabian Theis, Director of the Computational Health Center at Helmholtz Munich and Co-Chair of the AI Council for…

["AdobeStock_TEelMh.jpg","AdobeStock_791921363.jpeg"]

Researchers at Helmholtz Munich and the Technical University of Munich (TUM) together with international collaborators have conducted the largest genetic investigation of the restless legs syndrome to date. Their findings, published in Nature…

3D illustration of Heart, medical concept.

Multi-omics factor analysis furnishes new insights

An Interview with Dr. Eric Schulz about Foundation Models and Machine Psychology.

Ki - Künstliche Intelligenz verbessert Diagnose und Therapie

Artificial Intelligence (AI) offers various opportunities in medical research, but the use of patient data frequently raises privacy concerns. In a recent position paper, Dr. Carsten Marr, a scientist at Helmholtz Munich, and other authors address…

The German Radiological Society has awarded the Alfred Breit Prize this year to Prof. Julia Schnabel, Director at the Institute of Machine Learning in Biomedical Imaging at Helmholtz Munich and Professor at the Technical University of Munich. The…

The German National Academy of Sciences Leopoldina honors Helmholtz Munich AI scientist Niki Kilbertus for his teaching and research achievements in the field of ethical machine learning with the Leopoldina Prize for Young Scientists 2024.

Artificial intelligence in humanoid head with neural network thinks. AI with Digital Brain is learning processing big data, analysis information. Face of cyber mind. Technology background concept.

A Synergy Unit, in which Helmholtz Munich is involved, will develop, deploy, and connect foundation models.

The ISIDORe project is the largest and most diverse research and service-providing consortium in Europe dedicated to studying infectious diseases. As part of this project, a team around Dr Lara Urban, Principal Investigator at Helmholtz AI and the…

In a new collaboration, the Computational Health Center at Helmholtz Munich has teamed up with the global pharmaceutical company Pfizer. The joint initiative, spanning three years, aims to leverage Pfizer's vast knowledge and accumulated data in…

An interview with Prof. Fabian Theis, Head of the Computational Health Center, and Prof. Bjoern Eskofier, Group Leader for Translational Digital Health. The researchers hosted the first Munich Health Foundation Model Symposium on April 10, 2024, at…

Munich Health Foundation Model Symposium_with black

Helmholtz Munich is bringing together a wide range of experts to advance the development of foundation models focused on health research. The Munich Health Foundation Model Symposium, to be held on April 10, 2024, at the Helmholtz Munich Campus, aims…

Prof. Eleftheria Zeggini about equity, diversity and inclusion in science

The genetic information in our cells harbors secrets about the risks, progression, and complications of many diseases. With hundreds of millions of patients worldwide, identifying and understanding genetic risk for type 2 diabetes is of particular…

Researchers from Helmholtz Munich and Ludwig-Maximilians-Universität (LMU) have identified a mechanism that may explain the neurological symptoms of Long COVID. The study shows that the SARS-CoV-2 spike protein remains in the brain’s protective…

Prof. Ali Ertürk from Helmholtz Munich and the Ludwig-Maximilians-University Munich (LMU) has won the 2024 Falling Walls Award in Life Sciences for his pioneering research that integrates advanced tissue clearing techniques with AI. This breakthrough…

The research of Prof. Dr. Vasilis Ntziachristos and his team leads to novel, groundbreaking medical imaging tools. Their non-invasive technologies unveil crucial health and disease details that can empower doctors to identify and address diseases at…

Researchers at Helmholtz Munich and the LMU University Hospital Munich introduce DELiVR, offering a new AI-based approach to the complex task of brain cell mapping. The deep learning tool democratizes advanced neuroscience by eliminating the need for…

New method makes room for DNA insertions

EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV). The aim is to protect people from a range of serious…

Dr. Kurt Schmoller from the Institute of Functional Epigenetics at Helmholtz Munich has been awarded a prestigious European Research Council (ERC) Consolidator Grant. This significant recognition supports outstanding mid-career researchers in…

Cell death is indispensable to life, as it ensures the removal of damaged or unnecessary cells. Among the many ways a cell can die, ferroptosis is a unique and regulated form of cell death. This process plays a significant role in the pathogenesis of…

Prof. Marcus Conrad, Director of the Institute of Metabolism and Cell Death at Helmholtz Munich, was awarded the ECDO Honorary Award 2024 for his pioneering research on ferroptosis. He has been a Professor at the Technical University of Munich (TUM)…

Prof. Marcus Conrad, Director at the Institute of Metabolism and Cell Death at Helmholtz Munich, has been awarded the Galenus-von-Pergamon Award in the category of Basic Research. The honor recognizes his pioneering contributions to the field of…

The second "Helmholtz Summer School on Chromatin Biology: A Hands-on Expedition", organized by the Helmholtz Munich Institute of Epigenetics and Stem Cells (IES) and the Institute of Functional Epigenetics (IFE) in collaboration with the life science…

Prof. Michael Sattler on exploring the impact of understanding molecular disease mechanisms and advancing personalized therapies.

On June 12, 2024, the National Strategy for Gene and Cell Therapies was unveiled at the Futurium in Berlin.

Over the next four years, Helmholtz Munich participates in a European research consortium, aiming to develop an innovative technology that could boost the regeneration of neurons in diseases that currently have limited therapeutic options. The…

The X-ray of the human brain closeup image

In an ongoing phase 1 clinical trial targeting malignant glioblastoma, the initial patient has received a dosage of a novel drug candidate, derived from an antibody originating at Helmholtz Munich. This innovative compound, coupled with a…

Picture with Cas13d-NCS for Press Release in Cell Discovery 2024

The rise of RNA viruses like SARS-CoV-2 highlights the need for new ways to fight them. RNA-targeting tools like CRISPR/Cas13 are powerful but inefficient in the cytoplasm of cells, where many RNA viruses replicate. Scientists from Helmholtz Munich…

Close-up medical syringe with a vaccine.

Several research groups at Helmholtz Munich are working on innovative vaccines. Two of them are about to clear a crucial hurdle before approval - fighting the Epstein-Barr virus and Hepatitis B. But how do researchers develop a vaccine?

EU Project PerForM-REACT Strengthens Pandemic Preparedness Efforts

On March 11, 2024, the inauguration of the expanded safety laboratory in Augsburg marked a milestone within the EU-funded "PerForM-REACT" project, aimed at enhancing pandemic…

Epigenetic changes play important roles in cancer, metabolic and aging-related diseases, but also during loss of resilience as they cause the genetic material to be incorrectly interpreted in affected cells. A major study by scientists at Helmholtz…

test vitro Hepatitis B HBV to the hand in glove on a blue background

TherVacB, a novel therapeutic vaccine to combat chronic hepatitis B, entered the first clinical trial. The vaccine was designed and developed under the leadership of Helmholtz Munich. This phase 1a clinical trial is conducted at the Division of…

Leibniz-Preisträgerin 2025_© DFG David Ausserhofer Kopie_KI-Erweiterung des Hintergrundes

International Top Scientist from Helmholtz Munich Honored with Germany's Most Prestigious Research Award

Verleihung_Bayerischer Verdienstorden_Magdalena Götz

Prof. Magdalena Götz, Director of the Stem Cell Center and the Institute for Stem Cell Research at Helmholtz Munich, LMU Professor and Principal Investigator and Board Member of the SyNergy Cluster of Excellence, has been awarded the Bavarian Order…

Researchers at Helmholtz Munich and Ludwig-Maximilians-University (LMU) have shown how glial cells are reprogrammed into neurons via epigenetic modifications.

Helen Pynor Artist in Residence_KI-Erweiterung

Fostering creativity and out-of-the-box thinking – this is one of the key goals of the EU-funded project RepliFate spearheaded by Maria-Elena Torres-Padilla at Helmholtz Munich. The multidisciplinary and intersectoral consortium focuses on…

Prof. Magdalena Götz about the fascinating research on reprogramming glia cells and cell replacement therapy in the field of brain injuries

Prof. Maria-Elena Torres-Padilla im Interview

Prof. Maria-Elena Torres-Padilla about empowering a team and her enthusiasm for epigenetics.

Magdalena Goetz Hector Wissenschaftspreis

Prof. Dr. Magdalena Götz has been awarded this year's 150,000 euro science prize by the Hector Foundation. The jury is thus recognizing the neurobiologist's outstanding research achievements.

Life Science Factory Eröffnung Laborsicht

The Life Science Factory has opened its new site on the Helmholtz campus in Munich. Beginning in 2025, around 1,800 square meters of state-of-the-art laboratories and a flexible co-working space will be available for life science start-ups and…

A study led by Lara Urban, Principal Investigator at Helmholtz AI and the Pioneer Campus at Helmholtz Munich and TUM Junior Fellow at the Technical University of Munich (TUM), has revealed a novel method for detecting hidden antibiotic resistance,…

Researchers at Helmholtz Munich and Ludwig-Maximilians-University (LMU) have shown how glial cells are reprogrammed into neurons via epigenetic modifications.

A recent review published in Current Opinion in Cell Biology, authored by Jonathan Schneider and Dr. Marion Jasnin from the Helmholtz Pioneer Campus at Helmholtz Munich, illuminates the capabilities of cryo-electron tomography (cryo-ET) in unraveling…

Helmholtz Munich researcher Celia Martinez-Jimenez, principal investigator at the Pioneer Campus in the research group “Molecular Ageing”, and her team have unraveled the enigmatic world of hepatocyte polyploidy—a genomic phenomenon that proved to…

At the helm of a new era in vascular research, Prof. Matthias Meier and his team at the Helmholtz Pioneer Campus (HPC) at Helmholtz Munich, introduce a cutting-edge microfluidic vessel-on-chip technology. This innovation leverages human stem cells to…

Pioneer Campus researcher Janna Nawroth has secured 497.300 euros from the Volkswagen Foundation for a two-year project that focuses on investigating the role of motile cilia in the brain.

International Top Scientist from Helmholtz Munich Honored with Germany's Most Prestigious Research Award

Every year, the German Center for Diabetes Research (DZD) honors young researchers at the beginning of their careers with a DZD Award. This internal award recognizes outstanding scientific achievements in applied or clinical research presented at…

A Synergy Unit, in which Helmholtz Munich is involved, will develop, deploy, and connect foundation models.

Helmholtz Munich has successfully secured a substantial €500,000 grant from the Volkswagen Foundation to launch a comprehensive German Postdoc Network. This collaborative venture involves Helmholtz Munich, the Max Planck Institute of Biochemistry,…

Pioneer Campus researcher Janna Nawroth has secured 497.300 euros from the Volkswagen Foundation for a two-year project that focuses on investigating the role of motile cilia in the brain.

Prof. Dr. Magdalena Götz has been awarded this year's 150,000 euro science prize by the Hector Foundation. The jury is thus recognizing the neurobiologist's outstanding research achievements.

On this Page

Inceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapies

World Diabetes Day on November 14: Focus On Education and Early Detection of Diabetes

Helmholtz Munich at Bergson Kunstkraftwerk: From Concept to Reality – The Journey of the Weight Loss Injection

Funding for MicroRNA Research to Enhance Therapies in Type 1 Diabetes

Maria Keller receives the 2024 Research Prize of the German Obesity Society

Helmholtz Munich Opened Its Doors for "The Mouse"

DFG Funds HyperMet

Anette-Gabriele Ziegler Awarded Prestigious Rachmiel Levine Medal

11th Helmholtz Diabetes Conference Highlights Metabolic Research Innovations

Helmholtz Munich Receives Award from Breakthrough T1D to Fund AI-driven Diabetes Research

Early Detection of Type 1 Diabetes: New Position Paper Published

Bilal Sheikh Awarded Henriette-Herz Scout 2024

Experiencing Science: From Research to Community

Helmholtz Munich contributes to the National Strategy for Gene and Cell Therapies

Metabolic chambers inaugurated at HI-MAG - new research opportunities for analyzing human energy metabolism

Father's Diet Before Conception Influences Children's Health

Helmholtz Munich in the Bundestag: Artificial Intelligence and High-Tech

Anette-Gabriele Ziegler receives the Paul Langerhans Medal

SARS-CoV-2 and Type 1 Diabetes in Children: New Study Aims to Explore the Relationship

Prediction and Prevention are Key for Counteracting Type 1 Diabetes

Helmholtz Munich at the German Parliament: Breakthroughs in Common Diseases: Obesity and Diabetes

Fasting for Health: When Metabolism and Internal Clock are aligned

Scientists Reveal Adipocyte's Metabolic Role and Identify Treatment Targets

Obesity Prize for Excellence for Antje Körner

INFRAFRONTIER Achieves ERIC Status: Advancing Biomedical Research in Europe

Rising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Target

Striving for Optimal Healthcare

Unlocking Worm Strategies: A Path to Innovative Vaccines and Therapies

Genes and Lifestyle Are Both Crucial for Personalized Prevention

Second Munich-Chicago Lung Conference Highlights Environmental Risks and Disease Heterogeneity

Advising With Foresight: Claudia Traidl-Hoffmann Reappointed to the WBGU

Lancet Countdown 2024: Action Needed to Protect Health in the Face of Climate Change

Global Water Shortage: WBGU Calls for Climate-Resilient Water Management

Extreme Rainfall Poses Health Risks

Germany’s Largest Biorepository

DNA Repair Mechanisms: Varun Kumar Receives DFG Grant

Helmholtz Munich Contributes Expertise to Multi-Million DFG Project

Five ERC Starting Grants for Helmholtz Munich

Air Pollution and Mortality: Global Study Reveals Persistent Health Risks Despite Declining Pollutant Levels

German Study Prize of the Körber Foundation Awarded to Lena Cords

Staple Foods With Reasons for Concern

A High-Salt Diet Can Trigger Asthma

With the Help of AI: Additional Pollen Measuring Device Provides Details in Real-Time

New Study on the Impact of Extreme Temperatures on Health

Heat – When Temperatures Impacts Health

Long-Term Health Studies Show Effects of Heat with Evidence

Did you know? What makes you Resilient to Heat and Climate Change?

Night-time heat significantly increases the risk of stroke

New Study: Rural Environment and Long-Term Asthma Prevention

A Chemical Mystery Solved: The Reaction Explaining Large Carbon Sinks

What you eat is what you breathe

Asthma in Children: Researchers Envision Novel Drug to Reduce the Risk of the Disease

Tracking Down the Genetics of Tumors

Resilient to Climate Change and Preventing Allergies

Pandemic Preparedness: New High-Tech Laboratory in Augsburg

Exploring the Links Between Ageing, Environmental Stress and Lung Diseases

Disturbed Skin Flora Increases the Risk of Radiodermatitis

Cross-Country Collaboration: Targeting Resistant Cancers with New Therapeutics

Helmholtz Munich at Bergson Kunstkraftwerk: Fit for the Future – How is AI Revolutionizing Health and Medicine?

Carsten Marr Receives Eugen Münch Award

Understanding the Human Brain, One Cell at a Time

Helmholtz Munich Launches Imputation Server

“Extending the Limits of Our Curiosity With the Help of Technological Tools.”

Interview Stefan Bauer: Navigating the Frontiers of AI Research

New Collaborative Project: Artificial Intelligence That Recognizes Causal Relationships

Helmholtz Foundation Model Initiative Funds Two Pioneering Helmholtz Munich Projects

Modern Prevention of Health with AI and Bioengineering

Helmholtz Munich Team Wins “Frontiers of Science” Award

Ehrapy: A New Open-Source Tool for Analyzing Complex Health Data

Five ERC Starting Grants for Helmholtz Munich

Helmholtz Munich Receives Award from Breakthrough T1D to Fund AI-driven Diabetes Research

12 Million Euro Grant Awarded to SPACETIME for Lung Cancer Research

Building Reliable AI

Funding Boosts Expansion of Key Biomedical Tools

Medal of Honor for Holger Prokisch

Bavarian AI Council Meets at Helmholtz Munich

Restless Legs Syndrome: Genetic Discoveries Advance Treatment and Risk Prediction

Helmholtz Munich in the Bundestag: Artificial Intelligence and High-Tech

Signatures of heart attack